Clinical Laboratory Accreditation in Dubai: A Practical Guide to DHA-28

Every clinical decision begins with information — and a remarkable share of that information comes from the laboratory. A mislabeled specimen, an unverified method, or a critical value that sits unreported for an hour can change a patient's outcome as surely as any surgical error. That is why regulators hold clinical laboratories to exacting standards. In Dubai, those requirements are set out under DHA-28, the Clinical Laboratory Services standard governed by the Dubai Health Authority. This guide is for laboratory directors, quality managers, and pathology teams preparing for licensing, inspection, and accreditation in the Emirate.

What is DHA-28?

DHA-28 is the standard reference under which the Dubai Health Authority (DHA) defines how licensed clinical laboratories must operate within the Emirate of Dubai, United Arab Emirates. It applies the same fundamental logic found in international laboratory-quality frameworks: reliable results come not from good analyzers alone, but from a controlled total testing process — everything that happens from the moment a specimen is ordered to the moment a validated result reaches the clinician.

The standard therefore reaches across the entire laboratory operation: the pre-analytical phase where most errors originate, the analytical phase where methods and controls determine accuracy, and the post-analytical phase where reporting speed and integrity decide clinical usefulness.

Who does it apply to?

DHA-28 governs clinical laboratory services across public and private facilities in Dubai, including:

• Standalone diagnostic laboratories serving referring physicians and patients directly.
• Hospital and clinic laboratories operating as departments within larger facilities.
• The laboratory professionals — pathologists, scientists, technologists, and phlebotomists — whose qualifications and demonstrated competency the standard scrutinizes.

Any laboratory seeking or maintaining a DHA license in the Emirate needs a quality management system that answers DHA-28 clause by clause.

The benefits of a strong laboratory QMS

Laboratories that internalize DHA-28 gain much more than regulatory clearance:

• Fewer pre-analytical errors — disciplined collection, labelling, and transport controls attack the largest source of laboratory mistakes.
• Defensible results — validated methods, robust internal quality control, and proficiency-testing participation put analytical quality beyond dispute.
• Faster, safer reporting — structured critical-value identification and timely notification protect patients at their most vulnerable moments.
• Inspection confidence — clause-mapped documentation converts DHA inspection from an ordeal into a demonstration.
• Clinician trust — referring physicians reward laboratories whose quality is visible and consistent.

What DHA-28 expects your laboratory to control

The standard concentrates on the domains that determine result reliability:

• Specimen collection, labelling, transport, and handling — controlled pre-analytical processes that preserve specimen integrity and patient identification from draw to bench.
• Staff qualification and demonstrated competency — verified credentials plus documented, ongoing competency assessment for every role.
• External quality assessment and proficiency testing — regular participation, with review and corrective action on unacceptable results.
• Method validation and verification — objective evidence that every method performs as intended in your laboratory, on your instruments, with your staff.
• Internal quality control — daily control practices with defined acceptance rules and documented responses to failures.
• Critical value identification and timely reporting — defined critical limits, immediate notification pathways, and records proving they work.
• Laboratory Information System governance and integrity — controlled access, data integrity, and reliable interfaces between instruments, LIS, and reports.

The anatomy of a DHA-28 quality management system

Turning these expectations into daily practice requires a structured, controlled documentation system:

• Quality Manual — the top-level document defining scope, organization, and how the laboratory satisfies each DHA-28 domain.
• Procedures — for every pre-analytical, analytical, and post-analytical process, plus supporting activities such as equipment management, reagent control, and nonconformity handling.
• Forms and records — specimen rejection logs, QC charts, validation reports, competency assessments, critical-value notification records — the daily evidence stream inspectors follow.
• Record register and retention schedule — a documented answer to which records exist and how long each is retained.
• Training plan and competency matrix — mandatory training mapped to roles, with objective competency verification.
• Verification checklists — internal tools for auditing practice against the standard's clauses.
• Management review and continual improvement — leadership-level analysis of quality indicators, EQA performance, incidents, and audit findings, closed out through corrective action.

The road to licensing and accreditation readiness

A typical DHA-28 journey proceeds in six steps:

1. Gap analysis — map existing documents, records, and bench practice against every applicable DHA-28 clause.
2. Documentation build — write or adapt the manual, procedures, and forms needed to close the gaps.
3. Implementation — train staff, deploy procedures at the bench, and start generating genuine QC, validation, and competency records.
4. Internal audit — verify with clause-mapped checklists that practice matches paper across all three phases of testing; remediate findings.
5. DHA inspection — the regulator examines the facility, staff, and evidence trail; a traceable QMS lets you answer every question with a document and a record.
6. Ongoing compliance — sustain QC review, EQA participation, competency renewal, and document control throughout the inspection cycle.

Laboratories rarely fail on analytical science; they fail on evidence — the validation report never formalized, the competency assessment never documented, the retention schedule that exists only in someone's memory. A disciplined documentation framework closes those exposures permanently.

How AGS can help

The AGS DHA-28 Clinical Laboratory Services Documentation Toolkit (Tier C) translates the DOH/DHA expectations into a working quality management system suited to routine diagnostic operations — without months of drafting.

The package supplies a fully structured controlled-document set: a Quality Manual, a Management System Scheme and Master Document List, procedures, forms, a Record Register and Retention Schedule, verification checklists, standards-interpretation guidance, and a Mandatory Training Plan with Competency Matrix. Each item is mapped to the applicable DHA-28 clauses, giving your laboratory a clear, auditable line of evidence for inspection.

Every file is an editable Microsoft Word document, so laboratory management and quality personnel can tailor scope, test menus, escalation pathways, and local nomenclature to their own setting while preserving alignment with the regulatory framework. The result: faster licensing and accreditation readiness, more consistent pre-analytical and analytical practice, defensible record retention, and a durable platform for maintaining quality performance across every DHA inspection cycle. Visit the AGS online store to get your laboratory audit-ready sooner.

View the toolkit →